MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer

被引:1
|
作者
Xu, Wei [1 ]
Hang, Meng [1 ]
Yuan, Chen-Ye [1 ]
Wu, Fu-Lin [1 ]
Chen, Shu-Bo [1 ]
Xue, Kai [2 ]
机构
[1] Nanjing Med Univ, Affiliated Wuxi Hosp 2, Med Oncol, Wuxi 214002, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Med Oncol, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
Non-small cell lung cancer; miR-139-5p; insulin-like growth factor 1 receptor; PROMOTES; MIR-139-5P; APOPTOSIS; IGF1R;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Increasing evidence suggested that microRNAs (miRNAs) play a critical role in tumorigenesis. Decreased expression of miRNA-139-5p has been observed in various types of cancers. However, the biological function of miRNA-139-5p in non-small cell lung cancer (NSCLC) is still largely unknown. Methods: Quantitative real-time PCR (qRT-PCR) was used to explore the expression level of miRNA-139-5p in NSCLC tissues and cell lines. Then, we investigated the role of miRNA-139-5p to determine its potential roles on lung cancer cell proliferation, migration and invasion in vitro. A luciferase reporter assay was performed to confirm the target gene of miRNA-139-5p and the results were validated in renal cancer cells. Results: miRNA-139-5p was significantly decreased in NSCLC tissues and cell lines. Over-expression of miRNA-139-5p could inhibit lung cancer cell proliferation, migration, and invasion in vitro. Furthermore, we identified insulin-like growth factor 1 receptor (IGF1R) as a target of miR-139-5p and miR-139-5p function as a tumor suppressor via targeting IGF1R in NSCLC. Conclusions: Our results indicated that miR-139-5p acts as a tumor suppressor in NSCLC partially via down-regulating IGF1R expression.
引用
收藏
页码:3864 / 3870
页数:7
相关论文
共 50 条
  • [41] MicroRNA-133a inhibits the proliferation of non-small cell lung cancer by targeting YES1
    Shen, Yuyao
    Chen, Fangwei
    Liang, Yanchao
    ONCOLOGY LETTERS, 2019, 18 (06) : 6759 - 6765
  • [42] Combined inhibition of insulin-like growth factor-1 receptor enhances the effects of gefitinib in a human non-small cell lung cancer resistant cell line
    Qi, Hui Wei
    Shen, Zan
    Fan, Li Hong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (06) : 1091 - 1095
  • [43] Targeting the epidermal growth factor receptor in non-small cell lung cancer
    Herbst, RS
    Bunn, PA
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 5813 - 5824
  • [44] Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer
    Steins, Martin B.
    Reinmuth, Niels
    Bischoff, Helge
    Kindermann, Markus
    Thomas, Michael
    ONKOLOGIE, 2010, 33 (12): : 704 - 709
  • [45] miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor
    Zhao, Feng-Yi
    Han, Jing
    Chen, Xie-Wan
    Wang, Jiang
    Wang, Xu-Dong
    Sun, Jian-Guo
    Chen, Zheng-Tang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 (01) : 183 - 191
  • [46] Mutational analysis of the insulin-like growth factor 1 receptor tyrosine kinase domain in non-small cell lung cancer patients
    Gately, Kathy
    Forde, Lydia
    Gray, Stephen
    Morris, Derek
    Corvin, Aidan
    Tewari, Prerna
    O'Byrne, Kenneth
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (05) : 1073 - 1079
  • [47] Insulin-like growth factor-1 receptor-targeted therapy for non-small cell lung cancer: a mini review
    Yin, Ming
    Guan, Xiaoxiang
    Liao, Zhongxin
    Wei, Qingyi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2009, 1 (02): : 101 - 114
  • [48] MicroRNA-107-5p suppresses non-small cell lung cancer by directly targeting oncogene epidermal growth factor receptor
    Wang, Ping
    Liu, Xiaomin
    Shao, Yang
    Wang, Huimin
    Liang, Chen
    Han, Baohui
    Ma, Zhongliang
    ONCOTARGET, 2017, 8 (34) : 57012 - 57023
  • [49] MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5
    Liu, Xiang-hua
    Lu, Kai-hua
    Wang, Ke-ming
    Sun, Ming
    Zhang, Er-bao
    Yang, Jin-song
    Yin, Dan-dan
    Liu, Zhi-li
    Zhou, Jing
    Liu, Zhi-jun
    De, Wei
    Wang, Zhao-xia
    BMC CANCER, 2012, 12
  • [50] Different Roles of the Insulin-like Growth Factor (IGF) Axis in Non-small Cell Lung Cancer
    Xu, Xiongye
    Qiu, Yanli
    Chen, Simin
    Wang, Shuaishuai
    Yang, Ruifu
    Liu, Baomo
    Li, Yufei
    Deng, Jiating
    Su, Yan
    Lin, Ziying
    Gu, Jincui
    Li, Shaoli
    Huang, Lixia
    Zhou, Yanbin
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (25) : 2052 - 2064